Published: Aug 14, 2013
By David Pittman, Washington Correspondent, MedPage Today
WASHINGTON -- The FDA should have closed a Texas compounding pharmacy in March shortly after inspectors found sterility problems, an action that would have prevented the recent hospitalization of 15 patients, public health advocates charged Wednesday.
continue to read here
No comments:
Post a Comment